{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T19:34:21Z","timestamp":1785094461499,"version":"3.55.0"},"reference-count":106,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"MPP","award":["320148"],"award-info":[{"award-number":["320148"]}]},{"DOI":"10.13039\/100007688","name":"American University of Beirut","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007688","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.ejmech.2019.02.034","type":"journal-article","created":{"date-parts":[[2019,2,12]],"date-time":"2019-02-12T22:57:11Z","timestamp":1550012231000},"page":"562-582","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"special_numbering":"C","title":["Shooting three inflammatory targets with a single bullet: Novel multi-targeting anti-inflammatory glitazones"],"prefix":"10.1016","volume":"167","author":[{"given":"Perihan A.","family":"Elzahhar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rana","family":"Alaaeddine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1016-8950","authenticated-orcid":false,"given":"Tamer M.","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasha","family":"Nassra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azza","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin S.K.","family":"Chua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca L.","family":"Frkic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John B.","family":"Bruning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadja","family":"Wallner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tilo","family":"Knape","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"von Knethen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hala","family":"Labib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3432-3038","authenticated-orcid":false,"given":"Ahmed F.","family":"El-Yazbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9463-0844","authenticated-orcid":false,"given":"Ahmed S.F.","family":"Belal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2019.02.034_bib1","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.smim.2015.03.014","article-title":"The resolution of inflammation: principles and challenges","volume":"27","author":"Headland","year":"2015","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.ejmech.2019.02.034_bib2","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1096\/fj.201601222R","article-title":"Treating inflammation and infection in the 21st century: new hints from decoding resolution mediators and mechanisms","volume":"31","author":"Serhan","year":"2017","journal-title":"FASEB J."},{"key":"10.1016\/j.ejmech.2019.02.034_bib3","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.smim.2017.09.005","article-title":"The yin and yang of leukotriene B 4 mediated inflammation in cancer","volume":"33","author":"Jala","year":"2017","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.ejmech.2019.02.034_bib4","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/ni.3489","article-title":"Innate lymphoid cells as regulators of immunity, inflammation and tissue homeostasis","volume":"17","author":"Klose","year":"2016","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ejmech.2019.02.034_bib5","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.cell.2010.02.043","article-title":"Anti-inflammatory agents: present and future","volume":"140","author":"Dinarello","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2019.02.034_bib6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.amjcard.2005.11.010","article-title":"The metabolic syndrome: inflammation, diabetes mellitus, and cardiovascular disease","volume":"97","author":"Haffner","year":"2006","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ejmech.2019.02.034_bib7","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.diabres.2014.04.006","article-title":"Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes","volume":"105","author":"Esser","year":"2014","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.ejmech.2019.02.034_bib8","doi-asserted-by":"crossref","first-page":"9389784","DOI":"10.1155\/2018\/9389784","article-title":"Cardiac autonomic neuropathy as a result of mild hypercaloric challenge in absence of signs of diabetes: modulation by antidiabetic drugs","volume":"2018","author":"Al-Assi","year":"2018","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.ejmech.2019.02.034_bib9","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s11882-016-0628-3","article-title":"Lipid mediators of allergic disease: pathways, treatments, and emerging therapeutic targets","volume":"16","author":"Schauberger","year":"2016","journal-title":"Curr. Allergy Asthma Rep."},{"key":"10.1016\/j.ejmech.2019.02.034_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/568408","article-title":"Lipid mediators are critical in resolving inflammation: a review of the emerging roles of eicosanoids in diabetes mellitus","volume":"2015","author":"Tessaro","year":"2015","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.ejmech.2019.02.034_bib11","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.redox.2015.08.006","article-title":"Redox Biology the role of lipoxygenases in pathophysiology\u202f; new insights and future perspectives","volume":"6","author":"Mashima","year":"2015","journal-title":"Redox Biol."},{"key":"10.1016\/j.ejmech.2019.02.034_bib12","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.bbalip.2016.07.014","article-title":"The double-edged role of 12\/15-lipoxygenase during inflammation and immunity","volume":"1862","author":"Ackermann","year":"2017","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.ejmech.2019.02.034_bib13","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2147\/JIR.S90380","article-title":"Lipoxins: nature's way to resolve inflammation","author":"Sharma-walia","year":"2015","journal-title":"J.\u00a0Inflamm. Res."},{"key":"10.1016\/j.ejmech.2019.02.034_bib14","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1517\/13543776.2016.1113259","article-title":"15-Lipoxygenase inhibitors: a patent review","volume":"26","author":"Sadeghian","year":"2016","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.ejmech.2019.02.034_bib15","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1126\/science.294.5548.1871","article-title":"Prostaglandins and leukotrienes: advances in eicosanoid biology","volume":"294","author":"Funk","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2019.02.034_bib16","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.phrs.2009.01.011","article-title":"Nonsteroidal antiinflammatory drugs: past, present and future","volume":"59","author":"Patrono","year":"2009","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejmech.2019.02.034_bib17","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/S0006-2952(01)00747-X","article-title":"Dual inhibitors of cyclooxygenase and 5-lipoxygenase. A new avenue in anti-inflammatory therapy? 1 1Abbreviations: NSAIDs, nonsteroidal anti-inflammatory drugs; COX, cyclooxygenase; LT, leukotriene; 5-LOX, 5-lipoxygenase; PG, prostaglandin; DFU, 5,5-dimet","volume":"62","author":"Fiorucci","year":"2001","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2019.02.034_bib18","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0223-5234(03)00115-6","article-title":"Dual inhibition of cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX) as a new strategy to provide safer non-steroidal anti-inflammatory drugs","volume":"38","author":"Charlier","year":"2003","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.02.034_bib19","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.pharmthera.2015.11.011","article-title":"Small molecules with anti-inflammatory properties in clinical development","volume":"157","author":"Hanke","year":"2016","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejmech.2019.02.034_bib20","doi-asserted-by":"crossref","first-page":"11570","DOI":"10.1074\/jbc.M311773200","article-title":"A\u00a0novel pathway involving progesterone receptor, 12\/15-lipoxygenase-derived eicosanoids, and peroxisome proliferator-activated receptor gamma regulates implantation in mice","volume":"279","author":"Li","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2019.02.034_bib21","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3892\/ijmm.2014.1998","article-title":"Activation of PPAR\u03b3 by 12\/15-lipoxygenase during cerebral ischemia-reperfusion injury","volume":"35","author":"Han","year":"2015","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.ejmech.2019.02.034_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/816856","article-title":"Review of the structural and dynamic mechanisms of PPAR \u03b3 partial agonism","author":"Kroker","year":"2015","journal-title":"PPAR Res."},{"key":"10.1016\/j.ejmech.2019.02.034_bib23","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1210\/me.2013-1427","article-title":"Minireview: challenges and opportunities in development of PPAR agonists","volume":"28","author":"Wright","year":"2014","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.ejmech.2019.02.034_bib24","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.ejmech.2016.12.020","article-title":"Thiazolidinediones and PPAR orchestra as antidiabetic agents: from past to present","volume":"126","author":"Yasmin","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.02.034_bib25","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/med.21251","article-title":"Eicosanoids and their drugs in cardiovascular diseases: focus on atherosclerosis and stroke","volume":"33","author":"Capra","year":"2013","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2019.02.034_bib26","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ejphar.2017.03.007","article-title":"Pharmacological evidence for systemic and peripheral antinociceptive activities of pioglitazone in the rat formalin test: role of PPAR\u03b3 and nitric oxide","volume":"805","author":"Mansouri","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2019.02.034_bib27","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1021\/jm301653f","article-title":"Systematic exploration of dual-acting modulators from a combined medicinal chemistry and biology perspective","volume":"56","author":"Bornot","year":"2013","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.02.034_bib28","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1016\/j.bmc.2015.03.071","article-title":"Thiazolidine-2,4-dione derivatives: programmed chemical weapons for key protein targets of various pathological conditions","volume":"23","author":"Chadha","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.02.034_bib29","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ejmech.2017.02.031","article-title":"Therapeutic journey of 2,4-thiazolidinediones as a versatile scaffold: an insight into structure activity relationship","volume":"129","author":"Naim","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.02.034_bib30","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.ejmech.2017.09.031","article-title":"5-Ene-4-thiazolidinones \u2013 an efficient tool in medicinal chemistry","volume":"140","author":"Kaminskyy","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.02.034_bib31","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.ejmech.2010.12.019","article-title":"Synthesis, glucose uptake activity and structure-activity relationships of some novel glitazones incorporated with glycine, aromatic and alicyclic amine moieties via two carbon acyl linker","volume":"46","author":"Kumar","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.02.034_bib32","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00044-008-9152-x","article-title":"Design, synthesis, and docking studies of novel telmisartan\u2013glitazone hybrid analogs for the treatment of metabolic syndrome","volume":"18","author":"Chittiboyina","year":"2009","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2019.02.034_bib33","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1021\/jm00122a022","article-title":"Studies on hindered phenols and analogs. 1. Hypolipidemic and hypoglycemic agents with ability to inhibit lipid peroxidation","volume":"32","author":"Yoshioka","year":"1989","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.02.034_bib34","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ejphar.2016.04.038","article-title":"New thiazolidinediones affect endothelial cell activation and angiogenesis","volume":"782","author":"Rudnicki","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2019.02.034_bib35","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.ejps.2012.12.029","article-title":"Chemical synthesis, docking studies and biological effects of a pan peroxisome proliferator-activated receptor agonist and cyclooxygenase inhibitor","volume":"48","author":"Santin","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejmech.2019.02.034_bib36","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3858\/emm.2011.43.8.053","article-title":"5-(4-Hydroxy-2,3,5-trimethylbenzylidene) thiazolidine-2,4-dione attenuates atherosclerosis possibly by reducing monocyte recruitment to the lesion","volume":"43","author":"Choi","year":"2011","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.ejmech.2019.02.034_bib37","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.ejmech.2017.12.065","article-title":"Novel click modifiable thioquinazolinones as anti-inflammatory agents: design, synthesis, biological evaluation and docking study","volume":"144","author":"Moussa","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.02.034_bib38","doi-asserted-by":"crossref","first-page":"4027","DOI":"10.1021\/jm101360s","article-title":"Targeting peroxisome proliferator-activated receptors (PPARs): development of modulators","volume":"55","author":"Pirat","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.02.034_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-14776-0","article-title":"Novel benzylidene thiazolidinedione derivatives as partial PPAR\u03b3 agonists and their antidiabetic effects on type 2 diabetes","volume":"7","author":"Yasmin","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2019.02.034_bib40","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.phrs.2015.12.010","article-title":"New PPAR\u03b3 partial agonist improves obesity-induced metabolic alterations and atherosclerosis in LDLr\u2212\/\u2212 mice","volume":"104","author":"Silva","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejmech.2019.02.034_bib41","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1002\/cmdc.201402233","article-title":"Are 1,4- and 1,5-disubstituted 1,2,3-triazoles good pharmacophoric groups?","volume":"9","author":"Massarotti","year":"2014","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2019.02.034_bib42","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1021\/ci400115b","article-title":"Evaluation and optimization of virtual screening workflows with DEKOIS 2.0 \u2013 a public library of challenging docking benchmark sets","volume":"53","author":"Bauer","year":"2013","journal-title":"J.\u00a0Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2019.02.034_bib43","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1006\/jmbi.1996.0897","article-title":"Development and validation of a genetic algorithm for flexible docking11Edited by F. E. Cohen,","volume":"267","author":"Jones","year":"1997","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.ejmech.2019.02.034_bib44","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1021\/ci800298z","article-title":"Empirical scoring functions for advanced Protein\u2212Ligand docking with PLANTS","volume":"49","author":"Korb","year":"2009","journal-title":"J.\u00a0Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2019.02.034_bib45","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2009","journal-title":"J.\u00a0Comput. Chem."},{"key":"10.1016\/j.ejmech.2019.02.034_bib46","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13321-016-0139-1","article-title":"AutoDock VinaXB: implementation of XBSF, new empirical halogen bond scoring function, into AutoDock Vina","volume":"8","author":"Koebel","year":"2016","journal-title":"J.\u00a0Cheminf."},{"key":"10.1016\/j.ejmech.2019.02.034_bib47","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s11886-016-0702-4","article-title":"Cardiovascular effects of nonsteroidal anti-inflammatory drugs","volume":"18","author":"Patrono","year":"2016","journal-title":"Curr. Cardiol. Rep."},{"key":"10.1016\/j.ejmech.2019.02.034_bib48","doi-asserted-by":"crossref","first-page":"7898","DOI":"10.1016\/j.bmc.2006.07.047","article-title":"Synthesis and biological evaluation of a novel class of rofecoxib analogues as dual inhibitors of cyclooxygenases (COXs) and lipoxygenases (LOXs)","volume":"14","author":"Chen","year":"2006","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.02.034_bib49","doi-asserted-by":"crossref","first-page":"4752","DOI":"10.1016\/j.bmcl.2009.06.063","article-title":"Synthesis, characterization, and anti-melanoma activity of tetra-O-substituted analogs of nordihydroguaiaretic acid","volume":"19","author":"Meyers","year":"2009","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.02.034_bib50","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/ptr.1603","article-title":"Lipoxygenase inhibitors from natural plant sources. Part 1: medicinal plants with inhibitory activity on arachidonate 5 lipoxygenase and 5 lipoxygenase [sol] cyclooxygenase","volume":"19","author":"Schneider","year":"2005","journal-title":"Phyther. Res."},{"key":"10.1016\/j.ejmech.2019.02.034_bib51","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S0006-2952(02)01621-0","article-title":"Inhibition of 15-lipoxygenases by flavonoids: structure-activity relations and mode of action","volume":"65","author":"Sadik","year":"2003","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2019.02.034_bib52","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0021-9258(19)50908-5","article-title":"EFFECT OF INSULIN ON RAT DIAPHRAGM UNDER ANAEROBIC CONDITIONS","volume":"195","author":"Walaas","year":"1952","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2019.02.034_bib53","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.bioorg.2014.05.006","article-title":"Design, synthesis and glucose uptake activity of some novel glitazones","volume":"56","author":"Kar","year":"2014","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2019.02.034_bib54","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/j.1365-2443.2012.01607.x","article-title":"Ligand-dependent nucleo-cytoplasmic shuttling of peroxisome proliferator-activated receptors","volume":"17","author":"Umemoto","year":"2012","journal-title":"PPAR\u03b1 and PPAR\u03b3, Genes to Cells"},{"key":"10.1016\/j.ejmech.2019.02.034_bib55","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1755-148X.2012.01042.x","article-title":"Linking \u03b1MSH with PPAR\u03b3 in B16-F10 melanoma","volume":"26","author":"Maresca","year":"2013","journal-title":"Pigment Cell Melanoma. Res."},{"key":"10.1016\/j.ejmech.2019.02.034_bib56","series-title":"Biased Signal. Physiol. Pharmacol. Ther","first-page":"251","article-title":"Promises of biased signaling in the development of improved therapeutics","author":"Bosier","year":"2014"},{"key":"10.1016\/j.ejmech.2019.02.034_bib57","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.drudis.2015.08.003","article-title":"Structures of G protein-coupled receptors reveal new opportunities for drug discovery","volume":"20","author":"Cooke","year":"2015","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2019.02.034_bib58","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1254\/jphs.93.347","article-title":"Evaluation of human peroxisome proliferator-activated receptor (PPAR) subtype selectivity of a variety of anti-inflammatory drugs based on a novel assay for PPAR\u03b4(\u03b2)","volume":"93","author":"Kojo","year":"2003","journal-title":"J.\u00a0Pharmacol. Sci."},{"key":"10.1016\/j.ejmech.2019.02.034_bib59","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1126\/science.1142883","article-title":"Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior","volume":"317","author":"Auffray","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2019.02.034_bib60","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.cell.2011.04.005","article-title":"Macrophages in the pathogenesis of atherosclerosis","volume":"145","author":"Moore","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2019.02.034_bib61","doi-asserted-by":"crossref","DOI":"10.2337\/dc09-1315","article-title":"Unbalanced M1\/M2 phenotype of peripheral blood monocytes in obese diabetic patients: effect of pioglitazone","volume":"33","author":"Satoh","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ejmech.2019.02.034_bib62","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.cmet.2007.06.010","article-title":"PPAR\u03b3 activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties","volume":"6","author":"Bouhlel","year":"2007","journal-title":"Cell Metabol."},{"key":"10.1016\/j.ejmech.2019.02.034_bib63","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0094102","article-title":"Monocyte to macrophage differentiation goes along with modulation of the plasmalogen pattern through transcriptional regulation","volume":"9","author":"Wallner","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2019.02.034_bib64","doi-asserted-by":"crossref","first-page":"7303","DOI":"10.4049\/jimmunol.177.10.7303","article-title":"Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression","volume":"177","author":"Martinez","year":"2006","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ejmech.2019.02.034_bib65","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/nm.1905","article-title":"Bone marrow stromal cells attenuate sepsis via prostaglandin E2\u2013dependent reprogramming of host macrophages to increase their interleukin-10 production","volume":"15","author":"N\u00e9meth","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejmech.2019.02.034_bib66","doi-asserted-by":"crossref","first-page":"33405","DOI":"10.1074\/jbc.M704133200","article-title":"Class A scavenger receptor-mediated macrophage adhesion requires coupling of calcium-independent phospholipase A(2) and 12\/15-lipoxygenase to Rac and Cdc42 activation","volume":"282","author":"Nikolic","year":"2007","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2019.02.034_bib67","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1161\/hc2701.091070","article-title":"Biomechanical strain induces class a scavenger receptor expression in human monocyte\/macrophages and THP-1 cells: a potential mechanism of increased atherosclerosis in hypertension","volume":"104","author":"Sakamoto","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.ejmech.2019.02.034_bib68","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/jcp.24443","article-title":"15-LO\/15-HETE mediated vascular adventitia fibrosis via p38 MAPK-dependent TGF-\u03b2","volume":"229","author":"Zhang","year":"2014","journal-title":"J.\u00a0Cell. Physiol."},{"key":"10.1016\/j.ejmech.2019.02.034_bib69","doi-asserted-by":"crossref","first-page":"4319","DOI":"10.1111\/bph.13210","article-title":"15-Lipoxygenases regulate the production of chemokines in human lung macrophages","volume":"172","author":"Abrial","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2019.02.034_bib70","doi-asserted-by":"crossref","DOI":"10.1152\/ajplung.00036.2008","article-title":"15-Lipoxygenase-1 induces expression and release of chemokines in cultured human lung epithelial cells","volume":"297","author":"Liu","year":"2009","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.ejmech.2019.02.034_bib71","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1210\/en.2006-0665","article-title":"The role of 12\/15-lipoxygenase in the expression of interleukin-6 and tumor necrosis factor-alpha in macrophages","volume":"148","author":"Wen","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejmech.2019.02.034_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2011.07.002","article-title":"cPLA(2)\u03b1 gene activation by IL-1\u03b2 is dependent on an upstream kinase pathway, enzymatic activation and downstream 15-lipoxygenase activity: a positive feedback loop","volume":"23","author":"Walters","year":"2011","journal-title":"Cell. Signal."},{"key":"10.1016\/j.ejmech.2019.02.034_bib73","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1021\/acs.jmedchem.7b01780","article-title":"X-ray structures of target-ligand complexes containing compounds with assay interference potential","volume":"61","author":"Gilberg","year":"2018","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.02.034_bib74","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1021\/jm201243p","article-title":"Privileged scaffolds or promiscuous binders: a comparative study on rhodanines and related heterocycles in medicinal chemistry","volume":"55","author":"Mendgen","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.02.034_bib75","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13321-015-0074-6","article-title":"Applying DEKOIS 2.0 in structure-based virtual screening to probe the impact of preparation procedures and score normalization","volume":"7","author":"Ibrahim","year":"2015","journal-title":"J.\u00a0Cheminf."},{"key":"10.1016\/j.ejmech.2019.02.034_bib76","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1021\/ci600471m","article-title":"Unbiasing scoring Functions:\u2009 a new normalization and rescoring strategy","volume":"47","author":"Carta","year":"2007","journal-title":"J.\u00a0Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2019.02.034_bib77","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1021\/ci020055f","article-title":"Consideration of molecular weight during compound selection in virtual target-based database screening","volume":"43","author":"Pan","year":"2003","journal-title":"J.\u00a0Chem. Inf. Comput. Sci."},{"key":"10.1016\/j.ejmech.2019.02.034_bib78","first-page":"645","volume":"vol. 38","author":"Charlier","year":"2003"},{"key":"10.1016\/j.ejmech.2019.02.034_bib79","unstructured":"Molinspiration Cheminformatics, http:\/\/www.molinspiration.com\/cgi-bin\/properties, (n.d.)."},{"key":"10.1016\/j.ejmech.2019.02.034_bib80","unstructured":"M.L.L. C., http:\/\/molsoft.com\/mprop\/, (n.d.)."},{"key":"10.1016\/j.ejmech.2019.02.034_bib81","unstructured":"http:\/\/preadmet.bmdrc.org\/adme-prediction\/, (n.d.)."},{"key":"10.1016\/j.ejmech.2019.02.034_bib82","unstructured":"http:\/\/www.openmolecules.org\/datawarrior\/, (n.d.)."},{"key":"10.1016\/j.ejmech.2019.02.034_bib83","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1517\/17460441.2.4.469","article-title":"Ligand efficiency indices for effective drug discovery","volume":"2","author":"Abad-Zapatero","year":"2007","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.ejmech.2019.02.034_bib84","first-page":"430","article-title":"Ligand efficiency: a useful metric for lead selection, Drug Discov","volume":"9","author":"Hopkins","year":"2004","journal-title":"Today"},{"key":"10.1016\/j.ejmech.2019.02.034_bib85","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nrd4163","article-title":"The role of ligand efficiency metrics in drug discovery","volume":"13","author":"Hopkins","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2019.02.034_bib86","doi-asserted-by":"crossref","first-page":"3690","DOI":"10.1016\/j.bmcl.2013.04.086","article-title":"The development of CNS-active LRRK2 inhibitors using property-directed optimisation","volume":"23","author":"Kavanagh","year":"2013","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.02.034_bib87","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1039\/C0CC02472D","article-title":"Synthesis of phosphonamidate peptides by Staudinger reactions of silylated phosphinic acids and esters","volume":"47","author":"Wilkening","year":"2011","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ejmech.2019.02.034_bib88","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1002\/anie.200804689","article-title":"A\u00a0phosphine-mediated conversion of azides into diazo compounds","volume":"48","author":"Myers","year":"2009","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2019.02.034_bib89","first-page":"130","article-title":"Synthesis and biological evaluation of novel thiosemicarbazone \u2013 triazole hybrid compounds antimalarial agents","volume":"66","author":"Kinfe","year":"2013","journal-title":"S.\u00a0Afr. J. Chem."},{"key":"10.1016\/j.ejmech.2019.02.034_bib90","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1007\/s00044-016-1515-0","article-title":"Synthesis, characterization and antimicrobial activity of 4-((1-benzyl\/phenyl-1H-1,2,3-triazol-4-yl)methoxy)benzaldehyde analogues","volume":"25","author":"Lal","year":"2016","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2019.02.034_bib91","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s10616-005-2602-0","article-title":"Primary adipocyte culture: adipocyte purification methods may lead to a new understanding of adipose tissue growth and development","volume":"46","author":"Fernyhough","year":"2004","journal-title":"Cytotechnology"},{"key":"10.1016\/j.ejmech.2019.02.034_bib92","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.2337\/db14-1225","article-title":"Metformin inhibits monocyte-to-macrophage differentiation via AMPK-mediated inhibition of STAT3 activation: potential role in atherosclerosis","volume":"64","author":"Vasamsetti","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.ejmech.2019.02.034_bib93","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00011-007-6115-5","article-title":"Optimized THP-1 differentiation is required for the detection of responses to weak stimuli","volume":"56","author":"Park","year":"2007","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.ejmech.2019.02.034_bib94","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S1056-8719(00)00089-7","article-title":"An accurate and simple method for measurement of paw edema","volume":"43","author":"Fereidoni","year":"2000","journal-title":"J.\u00a0Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.ejmech.2019.02.034_bib95","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1016\/j.bbagen.2017.05.008","article-title":"X-ray crystal structure of rivoglitazone bound to PPAR\u03b3 and PPAR subtype selectivity of TZDs","volume":"1861","author":"Rajapaksha","year":"2017","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"10.1016\/j.ejmech.2019.02.034_bib96","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1107\/S0907444909047337","article-title":"Xds","volume":"66","author":"Kabsch","year":"2010","journal-title":"Acta Crystallogr. Sect. D Biol. Crystallogr."},{"key":"10.1016\/j.ejmech.2019.02.034_bib97","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1107\/S0907444906045975","article-title":"Solving structures of protein complexes by molecular replacement with Phaser","volume":"63","author":"McCoy","year":"2006","journal-title":"Acta Crystallogr. Sect. D Biol. Crystallogr."},{"key":"10.1016\/j.ejmech.2019.02.034_bib98","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1107\/S0907444912001308","article-title":"Towards automated crystallographic structure refinement with phenix.refine","volume":"68","author":"Afonine","year":"2012","journal-title":"Acta Crystallogr. Sect. D Biol. Crystallogr."},{"key":"10.1016\/j.ejmech.2019.02.034_bib99","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1107\/S0907444910007493","article-title":"Features and development of Coot","volume":"66","author":"Emsley","year":"2010","journal-title":"Acta Crystallogr. Sect. D Biol. Crystallogr."},{"key":"10.1016\/j.ejmech.2019.02.034_bib100","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/pro.3330","article-title":"MolProbity: more and better reference data for improved all-atom structure validation","volume":"27","author":"Williams","year":"2018","journal-title":"Protein Sci."},{"key":"10.1016\/j.ejmech.2019.02.034_bib101","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1107\/S1399004714028132","article-title":"FEM: Feature-enhanced map","volume":"71","author":"Afonine","year":"2015","journal-title":"Acta Crystallogr. Sect. D Biol. Crystallogr."},{"key":"10.1016\/j.ejmech.2019.02.034_bib102","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.ejmech.2004.06.007","article-title":"Synthesis and antimicrobial activities of some new 1-(5-phenylamino-[1,3,4]thiadiazol-2-yl)methyl-5-oxo-[1,2,4]triazole and 1-(4-phenyl-5-thioxo-[1,2,4]triazol-3-yl)methyl-5-oxo- [1,2,4]triazole derivatives","volume":"39","author":"Demirbas","year":"2004","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.02.034_bib103","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1758-2946-3-33","article-title":"Open Babel: an open chemical toolbox","volume":"3","author":"O'Boyle","year":"2011","journal-title":"J.\u00a0Cheminf."},{"key":"10.1016\/j.ejmech.2019.02.034_bib104","series-title":"Scientific, the PyMOL Molecular Graphics System, Version 1.1eval","author":"Delano","year":"2008"},{"key":"10.1016\/j.ejmech.2019.02.034_bib105","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1021\/acs.jcim.5b00475","article-title":"pROC-chemotype plots enhance the interpretability of benchmarking results in structure-based virtual screening","volume":"55","author":"Ibrahim","year":"2015","journal-title":"J.\u00a0Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2019.02.034_bib106","series-title":"KNIME: the Konstanz Information Miner BT - Data Analysis, Machine Learning and Applications","first-page":"319","author":"Berthold","year":"2008"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523419301485?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523419301485?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T13:51:30Z","timestamp":1759326690000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523419301485"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":106,"alternative-id":["S0223523419301485"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2019.02.034","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Shooting three inflammatory targets with a single bullet: Novel multi-targeting anti-inflammatory glitazones","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2019.02.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}